Document Detail


Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension.
MedLine Citation:
PMID:  6734275     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The potential short-term pulmonary vasodilator effect of a calcium-channel blocker, nifedipine, was tested in seven patients with primary pulmonary hypertension. Nifedipine (20 mg) produced a significant (p less than 0.01) and persistent decrease in mean pulmonary arterial pressure (58.1 +/- 14.3 to 48.6 +/- 16.3 mm Hg) and pulmonary vascular resistance (1,070 +/- 260 to 695 +/- 266 dynes X sec X cm-5). Cardiac index increased from 2.5 +/- 0.6 to 3.3 +/- 0.8 L/min/m2 (p less than 0.01), and heart rate was unchanged despite a fall in systemic pressure. In three patients tested during exercise on a bicycle, nifedipine resulted in an increase in the duration of exercise in two and a blunting of the exercise-induced increase in pulmonary pressure in all three. Long-term treatment was initiated in five of the seven patients and in two additional patients who did not receive nifedipine in the short-term study; all but one experienced symptomatic improvement. A persistent hemodynamic improvement was observed in three of the four patients restudied after long-term therapy. In conclusion, this study demonstrated the short-term beneficial hemodynamic effects of nifedipine, both at rest and during exercise. A more extensive long-term follow-up is necessary to establish the usefulness of this drug in the treatment of primary pulmonary hypertension.
Authors:
M T Olivari; T B Levine; E K Weir; J N Cohn
Related Documents :
8335575 - Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
2186235 - Exercise and chronic obstructive pulmonary disease.
15063815 - Effects of physical activity on intestinal gas transit and evacuation in healthy subjects.
2382905 - Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left ...
18635275 - The exercise training effects of skeletal muscle strength and muscle volume to improve ...
16842535 - Melatonin inhibits the expression of the inducible isoform of nitric oxide synthase and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chest     Volume:  86     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1984 Jul 
Date Detail:
Created Date:  1984-08-03     Completed Date:  1984-08-03     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  14-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Female
Hemodynamics / drug effects
Humans
Hypertension, Pulmonary / drug therapy*
Male
Middle Aged
Nifedipine / therapeutic use*
Physical Exertion*
Rest
Chemical
Reg. No./Substance:
21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary artery-bronchial fistula complicating chronic lymphocytic leukemia.
Next Document:  Aortic and mitral insufficiency complicating fulminant systemic lupus erythematosus.